Boston Scientific
Stock Forecast, Prediction & Price Target
Boston Scientific Financial Estimates
Boston Scientific Revenue Estimates
Boston Scientific EBITDA Estimates
Boston Scientific Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $11.88B N/A | $12.68B 6.67% | $14.24B 12.28% | Avg: $17.59B Low: $17.27B High: $17.75B avg. 23.57% | Avg: $19.30B Low: $19.02B High: $19.58B avg. 9.71% | Avg: $21.12B Low: $20.82B High: $21.43B avg. 9.43% | Avg: $22.80B Low: $22.47B High: $23.13B avg. 7.94% |
Net Income
% change YoY
| $1.04B N/A | $698M -32.94% | $1.59B 128.22% | Avg: $2.73B Low: $2.26B High: $3.02B avg. 71.69% | Avg: $3.26B Low: $2.60B High: $3.69B avg. 19.27% | Avg: $4.90B Low: $4.80B High: $4.99B avg. 50.24% | Avg: $5.47B Low: $5.36B High: $5.57B avg. 11.62% |
EBITDA
% change YoY
| $2.78B N/A | $2.8B 0.57% | $3.45B 23.32% | Avg: $3.82B Low: $3.75B High: $3.86B avg. 10.89% | Avg: $4.20B Low: $4.14B High: $4.26B avg. 9.71% | Avg: $4.59B Low: $4.53B High: $4.66B avg. 9.43% | Avg: $4.96B Low: $4.89B High: $5.03B avg. 7.94% |
EPS
% change YoY
| $0.69 N/A | $0.45 -34.78% | $1.08 140% | Avg: $1.81 Low: $1.55 High: $2.07 avg. 67.69% | Avg: $2.17 Low: $1.78 High: $2.53 avg. 20.07% | Avg: $3.35 Low: $3.29 High: $3.41 avg. 54.00% | Avg: $3.74 Low: $3.67 High: $3.81 avg. 11.62% |
Operating Expenses
% change YoY
| $6.30B N/A | $6.64B 5.42% | $7.55B 13.63% | Avg: $6.46B Low: $6.34B High: $6.52B avg. -14.40% | Avg: $7.09B Low: $6.98B High: $7.19B avg. 9.71% | Avg: $7.76B Low: $7.64B High: $7.87B avg. 9.43% | Avg: $8.37B Low: $8.25B High: $8.49B avg. 7.94% |
FAQ
What is Boston Scientific stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 38.20% in 2025-2028.
We have gathered data from 19 analysts. Their low estimate is 2.26B, average is 2.73B and high is 3.02B.
What is Boston Scientific stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 12.66% in 2025-2028.
We have gathered data from 24 analysts. Their low revenue estimate is $17.27B, average is $17.59B and high is $17.75B.
What is Boston Scientific stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 38.34% in 2025-2028.
We have gathered data from 19 analysts. Their low earnings per share estimate is $1.55, average is $1.81 and high is $2.07.
What is the best performing analyst?
In the last twelve months analysts have been covering Boston Scientific stock. The most successful analyst is William Plovanic whose win rate is 50%. He has correctly predicted 1/2 price targets.